tetano
Editor, Senior Moderator
Immunobiology. 2015 Feb 14. pii: S0171-2985(15)00023-6. doi: 10.1016/j.imbio.2015.02.002. [Epub ahead of print]
[h=1]Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus.[/h] Guo CY[SUP]1[/SUP], Tang YG[SUP]1[/SUP], Qi ZL[SUP]1[/SUP], Liu Y[SUP]1[/SUP], Zhao XR[SUP]1[/SUP], Huo XP[SUP]1[/SUP], Li Y[SUP]1[/SUP], Feng Q[SUP]1[/SUP], Zhao PH[SUP]1[/SUP], Wang X[SUP]1[/SUP], Li Y[SUP]1[/SUP], Wang HF[SUP]1[/SUP], Hu J[SUP]2[/SUP], Zhang XJ[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] To characterize the antigenic epitopes of the hemagglutinin (HA) protein of H1N1 influenza virus, a panel consisting of 84 clones of murine monoclonal antibodies (mAbs) were generated using the HA proteins from the 2009 pandemic H1N1 vaccine lysate and the seasonal influenza H1N1(A1) vaccines. Thirty-three (39%) of the 84 mAbs were found to be strain-specific, and 6 (7%) of the 84 mAbs were subtype-specific. Twenty (24%) of the 84 mAbs recognized the common HA epitopes shared by 2009 pandemic H1N1, seasonal A1 (H1N1), and A3 (H3N2) influenza viruses. Twenty-five of the 84 clones recognized the common HA epitopes shared by the 2009 pandemic H1N1, seasonal A1 (H1N1) and A3 (H3N2) human influenza viruses, and H5N1 and H9N2 avian influenza viruses. We found that of the 16 (19%) clones of the 84 mAbs panel that were cross-reactive with human respiratory pathogens, 15 were made using the HA of the seasonal A1 (H1N1) virus and 1 was made using the HA of the 2009 pandemic H1N1 influenza virus. Immunohistochemical analysis of the tissue microarray (TMA) showed that 4 of the 84 mAb clones cross-reacted with human tissue (brain and pancreas). Our results indicated that the influenza virus HA antigenic epitopes not only induce type-, subtype-, and strain-specific monoclonal antibodies against influenza A virus but also cross-reactive monoclonal antibodies against human tissues. Further investigations of these cross-reactive (heterophilic) epitopes may significantly improve our understanding of viral antigenic variation, epidemics, pathophysiologic mechanisms, and adverse effects of influenza vaccines.
Copyright ? 2015 Elsevier GmbH. All rights reserved.
[h=4]KEYWORDS:[/h] H1N1; HA protein; Human tissues, Heterophilic antigen epitopes; Influenza virus
PMID: 25708705 [PubMed - as supplied by publisher]
[h=1]Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus.[/h] Guo CY[SUP]1[/SUP], Tang YG[SUP]1[/SUP], Qi ZL[SUP]1[/SUP], Liu Y[SUP]1[/SUP], Zhao XR[SUP]1[/SUP], Huo XP[SUP]1[/SUP], Li Y[SUP]1[/SUP], Feng Q[SUP]1[/SUP], Zhao PH[SUP]1[/SUP], Wang X[SUP]1[/SUP], Li Y[SUP]1[/SUP], Wang HF[SUP]1[/SUP], Hu J[SUP]2[/SUP], Zhang XJ[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] To characterize the antigenic epitopes of the hemagglutinin (HA) protein of H1N1 influenza virus, a panel consisting of 84 clones of murine monoclonal antibodies (mAbs) were generated using the HA proteins from the 2009 pandemic H1N1 vaccine lysate and the seasonal influenza H1N1(A1) vaccines. Thirty-three (39%) of the 84 mAbs were found to be strain-specific, and 6 (7%) of the 84 mAbs were subtype-specific. Twenty (24%) of the 84 mAbs recognized the common HA epitopes shared by 2009 pandemic H1N1, seasonal A1 (H1N1), and A3 (H3N2) influenza viruses. Twenty-five of the 84 clones recognized the common HA epitopes shared by the 2009 pandemic H1N1, seasonal A1 (H1N1) and A3 (H3N2) human influenza viruses, and H5N1 and H9N2 avian influenza viruses. We found that of the 16 (19%) clones of the 84 mAbs panel that were cross-reactive with human respiratory pathogens, 15 were made using the HA of the seasonal A1 (H1N1) virus and 1 was made using the HA of the 2009 pandemic H1N1 influenza virus. Immunohistochemical analysis of the tissue microarray (TMA) showed that 4 of the 84 mAb clones cross-reacted with human tissue (brain and pancreas). Our results indicated that the influenza virus HA antigenic epitopes not only induce type-, subtype-, and strain-specific monoclonal antibodies against influenza A virus but also cross-reactive monoclonal antibodies against human tissues. Further investigations of these cross-reactive (heterophilic) epitopes may significantly improve our understanding of viral antigenic variation, epidemics, pathophysiologic mechanisms, and adverse effects of influenza vaccines.
Copyright ? 2015 Elsevier GmbH. All rights reserved.
[h=4]KEYWORDS:[/h] H1N1; HA protein; Human tissues, Heterophilic antigen epitopes; Influenza virus
PMID: 25708705 [PubMed - as supplied by publisher]